Home∕News & Press∕Featured∕ProFibrix US Phase II Study with FibrocapsTM Meets All Primary and Secondary Endpoints
ProFibrix FibrocapsTMUS:
Phase II Study with Meets All Primary and Secondary Endpoints
Jan. 4, 2012
Dr. Neil Singla, one of the Principal Investigators of the US Phase II study, said: “The combined ease of use and efficacy of Fibrocaps in spinal and vascular surgery constitute a great leap forward in hemostasis in these surgical settings